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Prolonged hypokalemia from chronic laxative abuse is recognized as the cause of
chronic tubulointerstitial disease, known as “hypokalemic nephropathy,” but it is not
clear whether it contributes to acute kidney injury (AKI). A 42-year-old woman with a
history of chronic kidney disease as a result of chronic laxative abuse from a purging
type of anorexia nervosa (AN-P), developed an anuric AKI requiring hemodialysis and a
mild AKI 2 months later. Both episodes of AKI involved severe to moderate hypokalemia
(1.2 and 2.7 mmol/L, respectively), volume depletion, and mild rhabdomyolysis. The
histologic ﬁndings of the ﬁrst AKI revealed the remnants of acute tubular necrosis with
advanced chronic tubulointerstitial nephritis and ischemic glomerular injury. Along
with these observations, the intertwined relationship among precipitants of recurrent
AKI in AN-P is discussed, and then we postulate a contributory role of hypokalemia
involved in the pathophysiology of the renal ischemia-induced AKI.
Copyright & 2015. The Korean Society of Nephrology. Published by Elsevier. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The term “kaliopenic nephropathy” was introduced by
Conn and Johnson [1] in 1956 to describe a distinct clinical
entity characterized by the pathologic lesions of vacuolar
tubulopathy and functional disorders such as impaired urine
concentration in patients resulting from long-term potassium
depletion. Since then, chronic laxative or diuretic abuse in
patients of anorexia nervosa of purging type (AN-P) has been
reported as a cause of chronic tubulointerstitial nephropathy
due to hypokalemic nephropathy, sometimes leading to end-
stage renal disease (ESRD) requiring renal replacement ther-
apy including dialysis or renal transplantation [2–4]. There15. The Korean Society of Nep
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).have been some reports of acute kidney injury (AKI) from
unidentiﬁed causes in preexisting chronic kidney disease
(CKD) due to hypokalemic nephropathy in the presence of
chronic hypokalemia in AN-P [2,4,5].
Through the present case, we wish to advance a postulate that
hypokalemia plays an important role in precipitating renal
ischemia-induced AKI in the presence of other contributors of AKI.Case report
A 42-year-old woman presented at the emergency depart-
ment (ED) with chief complaints of anergy and progressive
weakness of lower extremities for the past 10 days. She was
emaciated with a body mass index of 14 kg/m2 (weight 34 kg,
height 155 cm). On further questioning, she confessed to
having taken large amounts of three types of nonprescription
laxatives (up to 50 tablets daily) for at least 10 years after thehrology. Published by Elsevier. This is an open access article under the
Figure 1. Renal histology. (A) The interstitium shows marked ﬁbrosis
with mild mononuclear cell inﬁltration. The tubules show various
morphologic changes, including atrophy, detachment, and vacuolization
of the epithelial cells, with nuclear atypia, which suggest tubular injury
due to chronic damage (PAS, 200). (B) The glomeruli show focal
ischemic collapse (left) and segmental thickening of the glomerular
basement membrane (right). The arterioles are unremarkable (PAS,
400). (C) Electron microscopy shows diffuse thickening of the
glomerular basement membrane, with average thickness of 574 nm.
The foot processes are moderately effaced (3,500). PAS, periodic acid-
Schiff.
Kidney Res Clin Pract 34 (2015) 109–112110birth of her second child. The laxative dosage was increased
to almost 70 tablets a day over the previous month, and
during this period she developed progressive loss of appetite.
The laxatives contained bisacodyl, docusate sodium, sennoside
calcium, Lactobacillus acidophilus, and carbenoxolone
(glycyrrhetinic acid).
Vital signs in the supine position showed blood pressure
80/64 mmHg, heart rate 84/min, respiratory rate 24/min, and
body temperature 371C. She appeared severely volume
depleted with poor skin turgor, dry oral mucosa, and shiny
skin on both legs.
The initial laboratory data in the ED were as follows—
complete blood examination: white blood cell count 12.1
103/mm3, hemoglobin 9.0 g/dL, platelets 307103/mm3; serum
chemistry: sodium 127 mmol/L, potassium 1.2 mmol/L, chloride
94 mmol/L, urea nitrogen 117 mg/dL, creatinine 11.7 mg/dL, cal-
cium 6.3 mg/dL phosphate 8.5 mg/dL magnesium 2.2 mg/dL
intact parathyroid hormone 80 pg/mL, creatine phosphokinase
3,371 units/L (30–180 units/L). Arterial blood gas on 4 L oxygen
per minute showed pH 7.19, pO2 163 mmHg, pCO2 10.8 mmHg,
HCO3 4.2 mmol/L. Urinalysis yielded the following results: albu-
min (2þ), occult blood (2þ) with no red blood cells/high power
ﬁeld (HPF), pyuria 5–10/HPF with no bacteria.
A renal ultrasonogram on Day 3 showed 9.5 cm bilaterally
with prominent medulla and nephrolithiasis in the left renal
pelvis without hydronephrosis. In the supine position, the plasma
renin activity and aldosterone level was 15.29 ng/mL/h (0.68–
1.36 ng/mL/h) and 98.6 ng/dL (1.0–16 ng/dL), respectively. The
serologic markers for glomerulonephritis were negative.
In the ED and the intensive care unit, 3 L of a half-normal
saline mixed with KCl (60 mmol/L) and bicarbonate (100 mmol/
L) were infused over 12 hours. However, the patient remained
anuric (o5 mL/h) with serum potassium of 1.7 mmol/L, and the
electrocardiogram showed U waves, arterial pH 7.23, and blood
bicarbonate 8.4 mmol/L. Subsequently, hemodialysis with
4 mmol/L of potassium in the dialysate was initiated and
continued at a frequency of three times a week for 10 days until
the patient passed urine (4700–800 mL/d).
On Day 15, a kidney biopsy showed advanced chronic
tubulointerstitial nephritis with some evidence of acute tub-
ular necrosis (ATN). The predominant light microscopic lesions
were moderate to severe residual atrophy or loss of tubules
and scattered interstitial mononuclear cell inﬁltration (Fig. 1A).
Also, focal tubular degenerative change and mild regenerative
proximal tubules suggested ATN in the recovery phase, and a
few nonatrophic tubular epithelial cells in the proximal tubule
were focally enlarged and vacuolated. The glomeruli displayed
ischemic changes such as wrinkling and thickening of the
glomerular capillary walls but without advanced glomerular
lesions (Fig. 1B). However, there was no evidence of juxtaglo-
merular hyperplasia or arteriolosclerosis. Immunoﬂuorescence
examinations showed no immunoglobulins or complements.
Ultrastructurally, diffuse thickening of the glomerular base-
ment membrane was noted with no electron dense deposits.
Foot processes of podocytes showed moderate effacement
(Fig. 1C).
On the day of discharge, the patient weighed 38 kg with
serum potassium of 4.3 mmol/L and creatinine of 1.8 mg/dL.
After intensive counseling from renal, psychiatric, social, and
dietary consultants, she understood the seriousness of her
condition, and agreed to refrain from laxative abuse.
However, on the second monthly follow-up at the out-
patient renal clinic, her serum creatinine was increased to
Lee et al / Hypokalemic nephropathy 1112.7 mg/dL, which was also accompanied by decreased serum
potassium to 2.7 mmol/L and body weight to 36 kg. On careful
questioning, the patient admitted to resuming the intake of
laxatives (about 50–70 tablets/d). She was again counseled
about the serious renocardiac consequences of continued
laxative abuse and the necessity of regular psychiatric
follow-up for body image disorder. At the last follow-up 3
weeks later, her serum creatinine, serum potassium, and body
weight had improved to 1.9 mg/dL, 4.1 mmol/L, and 38 kg,
respectively.Discussion
The present case, based on clinical presentation and patho-
logical ﬁndings, describes two episodes of AKI due to severe
renal ischemia from severe hypokalemia, volume depletion,
and mild rhabdomyolysis, superimposed on preexisting CKD
with hypokalemic nephropathy.
Our patient had two major potential contributing factors for
AKI: severe volume depletion and rhabdomyolysis. The degree
of rhabdomyolysis in our patient on the basis of creatine
phosphokinase levels was quite mild and is unlikely to have
caused AKI, whereas volume depletion was quite severe and
could have precipitated AKI. By contrast, worsening hypoka-
lemia and profound volume depletion as the predisposing
factors for ischemic AKI appear to coexist in most AN-P cases.
However, only one report of AN-P has considered the cause of
AKI in detail; in that case, it was attributed to renal ischemia
from profound volume depletion in the setting of hypokalemia
(1.8–3.1 mmol/L), requiring transient hemodialysis with no
response to initial intravenous volume replacement, as in the
present case [5]. In a clinical study, 13 out of 40 patients with
AN-P with severe to moderate hypokalemia (1.9–2.8 mmol/L)
developed AKI, and this was attributed to hypovolemia alone
[4]. Cremer and Bock [2] reported ﬁve episodes of AKI in three
patients with AN-P, and did not note any apparent cause for
AKI such as volume depletion or rhabdomyolysis, except for
moderate hypokalemia (2.65–3.0 mm/L). In an animal study,
hypokalemia could potentiate ischemic AKI [6].
It is unlikely that hypovolemia in AN-P is the only under-
lying cause for the pathogenesis of ischemic AKI. Other factors
such as severe to moderate hypokalemia and/or rhabdomyo-
lysis appear to lead to severe renal ischemia from intense
intrarenal vasoconstriction and decreased activation of the
neurohumoral system responsible for intrarenal vasodilation, a
recognized factor in the pathophysiology of ischemic AKI [7].
In fact, one case report in a laxative abuser has suggested
volume depletion and hypokalemia-related tubular lesions as
causes of the anuric AKI, and termed it “hypokalemia-induced
acute renal failure” [8]. Patients with long-term AN-P who are
diuretic or laxative abusers are constantly at a risk of chronic
potassium deﬁciency, either owing to direct loss of potassium
by the renal and/or extrarenal route or to high levels of
angiotensin II and aldosterone as a result of activation of the
renin–angiotensin–aldosterone system secondary to hypovo-
lemia following the loss of water and salt induced by purging
combined with restricted food intake. Therefore, the hypoka-
lemic nephropathy and AKI in chronic laxative abusers with
AN-P appear to involve two major factors—hypokalemia and
hypovolemia. These result in renal ischemia as follows: (1) The
hypokalemia stimulates increased ammoniagenesis, which
in turn activates the alternative complement pathwayreleasing proinﬂammatory cytokines and proﬁbrotic mole-
cules.
(2) The hypokalemia also stimulates the production of vaso-
active mediators, resulting in increased vasoconstrictor stimuli
(endothelin-1, thromboxane B2, angiotensin-converting
enzyme, angiotensin II) and reduced vasodilatory mediators
such as prostaglandin E2 and endothelium-derived relaxing
factor. (3) The hypovolemia causes renal ischemia directly,
with activation of the renin–angiotensin–aldosterone system
[9–13].
In the present case, the most likely cause of the intermittent
or recurrent AKI was renal ischemia due to intrarenal vaso-
constriction caused by the worsening of hypokalemia and
hypovolemia. However, the preexisting CKD due to long-
standing hypokalemic nephropathy was also an important
factor in the patient’s recurrent episodes of AKI. The histolo-
gical ﬁndings from the kidney biopsy performed on Day 15
showed ATN with focal tubular degenerative change including
mild regenerative and vacuolar proximal tubules, and promi-
nent chronic tubulointerstitial nephritis combined with diffuse
ischemic glomerular changes such as wrinkling and thickening
of the glomerular basement membrane (Figs. 1A–1C). The
clinicopathological ﬁndings compatible with hypokalemic
nephropathy showed that tubulopathy alone may lead to
CKD as a result of tubulointerstitial ﬁbrosis, as in the renal
ﬁbrosis in CKD due to glomerulopathy. Our ﬁndings also
support a contributory role of AKI in the progression of CKD
in patients with AN-P involving a vicious cycle of the preexist-
ing CKD and repeated episodes of AKI. Underlying CKD is a
major predisposing factor for AKI, and recurrent AKI super-
imposed on CKD may increase the rate of loss of the remaining
nephron mass [14].
In conclusion, episodes of worsening hypokalemia in AN-P
could play an important role in the progression of the
preexisting CKD with hypokalemic nephropathy, as suggested
in a recent study that shows hypokalemia in CKD to be a risk
factor for progression to ESRD [15]. Health providers involved
in the care of patients with hypokalemic nephropathy, parti-
cularly patients with AN-P, should address potassium deple-
tion and hypovolemia as well as offer intensive counseling to
encourage the patients to abstain from purgative drug abuse.Conﬂict of interest
All authors declare no conﬂict of interest.Acknowledgments
The authors deeply appreciate Dr Man S. Oh, State Uni-
versity of New York, Health Science Center at Brooklyn, who
patiently advised us for the postulate of this manuscript with
his critical comments and opinions.
References
[1] Conn JW, Johnson RD: Kaliopenic nephropathy. Am J Clin Nutr
4:523–528, 1956
[2] Cremer W, Bock KD: Symptoms and course of chronic hypo-
kalemic nephropathy in man. Clin Nephrol 7:112–119, 1977
[3] Abdel-Rahman EM, Moorthy AV: End-stage renal disease (ESRD)
in patients with eating disorders. Clin Nephrol 47:106–111, 1997
Kidney Res Clin Pract 34 (2015) 109–112112[4] Riemenschneider T, Bohle A: Morphologic aspects of low-potassium
and low-sodium nephropathy. Clin Nephrol 19:271–279, 1983
[5] Copeland PM: Renal failure associated with laxative abuse.
Psychother Psychosom 62:200–202, 1994
[6] Seguro AC, Shimizu MHM, Monteiro JL, Rocha AS: Effect of potassium
depletion on ischemic renal failure. Nephron 51:350–354, 1989
[7] Sharfuddin AA, Molitoris BA: Pathophysiology of ischemic acute
kidney injury. Nat Rev Nephrol 7:189–200, 2011
[8] Menahem SA, Perry GJ, Dowling J, Thomson NM: Hypokalaemia-
induced acute renal failure. Nephrol Dial Transplant 14:2216–2218,
1999
[9] Walsh SB, Unwin E, Vargas-Poussou R, Houillier P, Unwin R: Does
hypokalaemia cause nephropathy? An observational study of
renal function in patients with Bartter or Gitelman syndrome
QJM 104:939–944, 2011[10] Li Cavoli G, Mulè G, Rotolo U: Renal involvement in psychological
eating disorders. Nephron Clin Pract 119:c338–c341, 2011
[11] Cronin RE, Thompson JR: Role of potassium in the pathogenesis of
acute renal failure. Miner Electrolyte Metab 17:100–105, 1991
[12] Linas SL, Dickmann D:Mechanism of the decreased renal blood ﬂow in
the potassium-depleted conscious rat. Kidney Int 21:757–764, 1982
[13] Beck N, Show JO: Thromboxane B2 and prostaglandin E2 in the
Kþ-depleted rat kidney. Am J Physiol 240:F151–F157, 1981
[14] Venkatachalam MA, Grifﬁn KA, Lan R, Geng H, Saikumar P, Bidani
AK: Acute kidney injury: a springboard for progression in chronic
kidney disease. Am J Physiol Renal Physiol 298:F1078–F1094, 2010
[15] Korgaonkar S, Tilea A, Gillespie BW, Kiser M, Eisele G, Finkelstein
F, Kotanko P, Pitt B, Saran R: Serum potassium and outcomes in
CKD: insights from the RRI-CKD cohort study. Clin J Am Soc
Nephrol 5:762–769, 2010
